RankAlpha logo
Back to Rankings

LYEL

Lyell ImmunopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LYEL vs peer average
32/100
LYEL vs. peer average (F vs. D)
Grade spread
B 1 · C 2 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IKT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $333.49M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIKTInhibikase Therapeutics
LYEL
Lyell Immunopharma
IKT
Inhibikase Therapeutics
Grade
F
F
Momentum
12
84
Value
41
41
Sentiment
-
29
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs IKT

LYEL / IKT
Grade Position
Below peers
LYEL vs. peer average (F vs. D)
32/100
Momentum
12
IKT
Value
41
LYEL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LYEL
1
IKT
Inhibikase Therapeutics Inc Common
F
20/100
Even
2
IMRX
Immuneering Corp Class A Common
C
60/100
-2
3
VCRE
Vicore Pharma Holding AB ADR
N/A
-
-
4
TLSI
TriSalus Life Sciences Inc Common
F
20/100
Even
5
ABEO
Abeona Therapeutics Inc Common
B
80/100
-3
IKT is the first peer returned for this comparison set.